UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 6
June-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1908376


Registration ID:
224799

Page Number

494-508

Share This Article


Jetir RMS

Title

EFFICACY OF PYOCYANIN, EXTENDED-SPECTRUM BETA-LACTAMASE AND HCN PRODUCTION IN PSEUDOMONAS AERUGINOSA IN CLINICAL SETTINGS – AN EMERGING THREAT

Abstract

Emergence of multi drug resistant bacterial strains is a growing global concern and in particular strains of Pseudomonas aeruginosa acquires various significant virulent characters frequently and they are always versatile than other groups of bacteria in acquiring drug resistant mechanism. Cyanogenesis, Pyocyanin and extended spectrum of beta lactamase (ESBL) production makes this bacteria more virulent than other pathogens in the current scenario. Hence the study is sought for the detection of cyanogenesis and ESBL production among the clinically recovered isolates. The results exposed that among the isolated Pseudomonas aeruginosa strains 17.64% produced high and 35.2% produced low and 47% with no cyanide production, 58.8% of the strains produce pyocyanin a phenazine compound, ranging from (3.02 - 9.38µg/mL) Further its antibacterial activity also were estimated during the investigation. The pigment produced significant antibacterial activity against other clinical pathogen. 67.7% were ESBL producers which indicates that the organism should be given more attention during treatment and other clinical studies. The ESBL confers more drug resistant characters to the bacterium. The result also concluded that treatment for Pseudomonas aeruginosa infections should include cyanide detoxifying agent and based on that, drug should be chosen for effective treatment

Key Words

HCN production, ESBL, MAR index ,Pseudomonas aeruginosa, Pyocyanin

Cite This Article

"EFFICACY OF PYOCYANIN, EXTENDED-SPECTRUM BETA-LACTAMASE AND HCN PRODUCTION IN PSEUDOMONAS AERUGINOSA IN CLINICAL SETTINGS – AN EMERGING THREAT", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 6, page no.494-508, June 2019, Available :http://www.jetir.org/papers/JETIR1908376.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"EFFICACY OF PYOCYANIN, EXTENDED-SPECTRUM BETA-LACTAMASE AND HCN PRODUCTION IN PSEUDOMONAS AERUGINOSA IN CLINICAL SETTINGS – AN EMERGING THREAT", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 6, page no. pp494-508, June 2019, Available at : http://www.jetir.org/papers/JETIR1908376.pdf

Publication Details

Published Paper ID: JETIR1908376
Registration ID: 224799
Published In: Volume 6 | Issue 6 | Year June-2019
DOI (Digital Object Identifier):
Page No: 494-508
Country: Vellore, Tamil nadu, South India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002791

Print This Page

Current Call For Paper

Jetir RMS